Unicycive Therapeutics, Inc.
UNCY
$5.09
$0.061.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.35M | 6.83M | 4.97M | 4.38M | 5.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.14M | 8.44M | 7.22M | 7.34M | 6.96M |
| Operating Income | -10.14M | -8.44M | -7.22M | -7.34M | -6.96M |
| Income Before Tax | -1.72M | -12.82M | -14.67M | -6.01M | -6.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.72M | -12.82M | -14.67M | -6.01M | -6.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.72M | -12.82M | -14.67M | -6.01M | -6.45M |
| EBIT | -10.14M | -8.44M | -7.22M | -7.34M | -6.96M |
| EBITDA | -10.13M | -8.43M | -7.21M | -7.33M | -6.96M |
| EPS Basic | -0.06 | -0.54 | -0.68 | -0.33 | -0.52 |
| Normalized Basic EPS | -0.04 | -0.34 | -0.43 | -0.21 | -0.33 |
| EPS Diluted | -0.06 | -0.54 | -0.68 | -0.33 | -0.52 |
| Normalized Diluted EPS | -0.04 | -0.34 | -0.43 | -0.21 | -0.33 |
| Average Basic Shares Outstanding | 26.92M | 23.91M | 21.43M | 18.07M | 12.30M |
| Average Diluted Shares Outstanding | 26.92M | 23.91M | 21.43M | 18.07M | 12.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |